MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sinclair IS Pharma PLC Company Profile (LON:SPH)

Consensus Ratings for Sinclair IS Pharma PLC (LON:SPH) (?)
Ratings Breakdown: 6 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: GBX 41.86

Current Analysts' Coverage Summary for Sinclair IS Pharma PLC (LON:SPH)
Show:
DateFirmActionRatingPrice TargetActions
8/5/2015Stifel NicolausDowngradeHoldGBX 48View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015N+1 SingerReiterated RatingHoldGBX 36View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015FinnCapDowngradeHoldGBX 43View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Canaccord GenuityReiterated RatingBuyGBX 44View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Oriel Securities LtdReiterated RatingAddGBX 40View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015InvestecBoost Price TargetHoldGBX 34 -> GBX 37View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2014Jefferies GroupReiterated RatingBuyGBX 45View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2014Credit SuisseUpgradeNeutralGBX 3View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha